Glenmark Pharmaceuticals launches Bumex Injection generic in US
Glenmark Pharmaceuticals said that its US-based subsidiary has launched Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) SingleDose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multi-Dose Vials. The launched product is the generic version of Validus Pharmaceuticals’ Bumex Injection, 0.25 mg/mL. Bumex is indicated for the treatment of swelling and high blood pressure. As per […]